Sarepta investor: High drug prices are good By: CNBC.com News May 05, 2016 at 16:50 PM EDT If you can't charge "hundreds of thousands" of dollars a year for drugs, there will be no drugs for orphan diseases, an investor says. Read More >> Related Stocks: Nasdaq Biotechnology Ishares ETF Sarepta Therapeutics